New antifungal approved for aspergillosis
June 17th 2002Pfizer recently announced that it has received marketing approval from the US Food and Drug Administration for voriconazole (Vfend tablets) and voriconazole for injection (Vfend I.V.) for use in the treatment of invasive aspergillosis and the treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium spp in patients intolerant of, or refractory to, other therapy.
New injection approved to treat infertility
June 3rd 2002The US Food and Drug Administration (FDA) recently approved urofollitropin for injection, purified (Bravelle, Ferring Pharmaceuticals) for the treatment of infertility. Urofollitropin is a highly purified follicle-stimulating hormone derived from the urine of postmenopausal women